The increase in CD4 T cells predicts a better prognosis in medulloblastoma patients, particularly within the SHH and non-WNT/non-SHH subgroups, and they might be taken as a therapeutic target for medulloblastoma. The gene discussed is CD4; the disease is medulloblastoma.